@article{ATM26709,
author = {Luca Saba and Antonella Balestrieri and Alessandra Serra and Raimondo Garau and Carola Politi and Pierleone Lucatelli and Alessandro Murgia and Jasjit S. Suri and Lorenzo Mannelli},
title = {FOCUS trial: results, potentialities and limits},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 3},
year = {2019},
keywords = {},
abstract = {In January 2019 Lancet has published the paper “Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial” (1). The main purpose of this prospective trial was to asses if fluoxetine [a selective serotonin reuptake inhibitor (SSRI) drug] could improve recovery after stroke.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/26709}
}